Skip to content

Serotonin: all studies

Page 74 of 400: studies 731 to 740 of 3,999, newest first. Back to the serotonin overview

Research

Functional selectivity at the serotonin 2A receptor: differential signaling by serotonin and dimethylated tryptamines

The FASEB Journal April 1, 2010 Cullen L. Schmid, Laura M Bohn

Serotonin and the hallucinogenic metabolites of tryptamines, dimethylated tryptamines, activate the serotonin 2A receptor (5‐HT2AR), which is implicated in numerous mental health disorders. We have previously demonstrated that the 5‐HT2AR is differentially regulated by βarrestin2 (βarr2) depending upon the agonist; here we utilized βarr2 knockout mice to compare signaling profiles in vivo, by...

Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.

Journal of Pharmacology and Experimental Therapeutics April 1, 2010 Jun-Xu Li, Wouter Koek, Kenner C Rice et al. 17 citations

Although many drugs act by indirectly stimulating multiple receptors (e.g., reuptake inhibitors), relatively little is known about interactions between agonism at different receptors. This study compared the effect of serotonin (5-HT)(1A) receptor agonists with the discriminative stimulus effects of the 5-HT(2A) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats and...

DOI: 10.1124/jpet.109.163451 (opens in new tab) Full text (opens in new tab) Species differences Interspecies variation Comparative pharmacology Animal model differences +20

Psilocybin slows binocular rivalry switching through serotonin modulation

Journal of Vision March 19, 2010 Olivia Carter, John D. Pettigrew, Felix Hasler et al. 3 citations

Binocular rivalry refers to the fluctuations in visual awareness/suppression that occur when different images are simultaneously presented to each eye. To explore the role of serotonin (5-HT) in binocular rivalry, this study investigated the affects of the hallucinogenic 5-HT1A&2A receptor agonist psilocybin (the active compound in “magic mushrooms”), alone and after pretreatment with the...

Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors

Journal of Vision March 17, 2010 Olivia Carter, David C. Burr, John D. Pettigrew et al. 6 citations

Increasing evidence suggests a link between attention, working memory, serotonin (5-HT) and prefrontal cortex activity. In an attempt to tease out the relationship between these elements, this study tested the effects of the hallucinogenic 5-HT1A/2A receptor agonist psilocybin alone and after pretreatment with the 5-HT2A antagonist ketanserin on multiple object tracking and spatial working...

The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen

Psychopharmacology February 19, 2010 Clinton E. Canal, U. B. Olaghere da Silva, Paul J Gresch et al. 111 citations

RationaleHallucinogenic serotonin 2A (5-HT2A) receptor partial agonists, such as (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI), induce a frontal cortex-dependent head-twitch response (HTR) in rodents, a behavioral proxy of a hallucinogenic response that is blocked by 5-HT2A receptor antagonists. In addition to 5-HT2A receptors, DOI and most other serotonin-like...

Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice

Frontiers in Neuroscience 2010 Weber 201 citations

Serotonin receptors of the 5-HT(2A) subtype are robustly expressed in the cerebral cortex where they have been implicated in the pathophysiology and therapeutics of mental disorders and the actions of hallucinogens. Much less is known, however, about the specific cell types expressing 5-HT(2A) receptors in cortex. In the current study we use immunohistochemical and electrophysiological...

DOI: 10.3389/fnins.2010.00036 (opens in new tab) Parvalbumin Gabaergic Cortex anatomy Receptor +7

Peduncular hallucinosis: a polysomnographic and spect study of a patient and efficacy of serotonergic therapy.

Sleep Medicine December 2009 Roberto Vetrugno, Alessandra Vella, Mario Mascalchi et al.

Peduncular hallucinosis (PH) consists of formed and coloured visual images, which the patient knows are unreal; it is often associated with lesions of the pons, midbrain and diencephalon. A 72-year-old man had noted the sudden onset of visual hallucinations one year before, specifying the time and body position in a 4-week, 24-h diary. Thereafter, he underwent video-polysomnography (VPSG),...

Brain serotonin, psychoactive drugs, and effects on reproduction.

Central nervous system agents in medicinal chemistry December 1, 2009 María Elena Ayala

Serotonin, a biogenic amine, is present in significant amounts in many structures of the CNS. It is involved in regulation of a wide variety of physiological functions, such as sensory and motor functions, memory, mood, and secretion of hormones including reproductive hormones. It has also been implicated in the etiology of a range of psychiatric disorders such as anxiety, depression, and...

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity

Journal of Neurochemistry November 30, 2009 Dominik K. Biezonski, Jerrold S. Meyer 47 citations

J. Neurochem. (2009) 112 , 951–962. Abstract 3,4‐Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) is a popular recreational drug used worldwide. This study aimed to determine the effects of this compound on the expression of nerve terminal serotonergic markers in rats. Experiment 1 investigated MDMA‐induced changes in levels of the serotonin transporter (SERT) and the vesicular monoamine...

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor

Psychopharmacology November 24, 2009 Adam L. Halberstadt, Mark A. Geyer 76 citations

RATIONALE: Compounds that activate the 5-HT(2A) receptor, such as lysergic acid diethylamide (LSD), act as hallucinogens in humans. One notable exception is the LSD congener lisuride, which does not have hallucinogenic effects in humans even though it is a potent 5-HT(2A) agonist. LSD and other hallucinogens have been shown to disrupt prepulse inhibition (PPI), an operational measure of...